Related Experiment Videos

ChlVPP: reducing toxicity in the treatment of Hodgkin's disease

¹St. George's Hospital Medical School, London, U.K.

European Journal of Cancer (Oxford, England : 1990)

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study).

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.

British journal of cancer·2012

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

The role of bisphosphonates in breast cancer management: review article.

Current medical research and opinion·2002

The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.

British journal of cancer·2002

See all related articles